Literature DB >> 1491361

Behavioral markers of schizophrenia useful for genetic studies.

P S Holzman1.   

Abstract

The advent of powerful molecular biological techniques have already led to the discovery of chromosomal loci linked to some genetically transmitted diseases. These techniques, however, lose their power if applied to a disease trait that is not Mendelian in its transmission. The low familial prevalence of psychiatric diseases such as schizophrenia make these techniques unsuitable for linkage studies of these conditions, if identification of schizophrenia relies solely on the clinical manifestation of the schizophrenic psychosis. Broadening the disease phenotype in diseases such as schizophrenia, with low recurrence risk, and narrowing it in diseases such as major affective disorder, with very high recurrence risk, may be an effective strategy for linkage studies of these diseases. Several alternative phenotypes are discussed, including smooth pursuit eye movement abnormalities, event related potentials, and deficient attentional deployment as measured by the continuous performance test. The strategy assumes that schizophrenia is a pleiotropic disorder, and that the psychosis is the rare form of the condition. The paper focuses principally on smooth pursuit eye movement abnormalities, and claims a plausible place for them as an independent expression of schizophrenia. With this strategy, the possibility for successful linkage studies increases, since familial distributions of schizophrenia and pursuit abnormalities, considered together, appear to fit an autosomal dominant pattern.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491361     DOI: 10.1016/0022-3956(92)90044-o

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  10 in total

1.  Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis.

Authors:  Rebekka Lencer; Jeffrey R Bishop; Margret S H Harris; James L Reilly; Shitalben Patel; Rick Kittles; Konasale M Prasad; Vishwajit L Nimgaonkar; Matcheri S Keshavan; John A Sweeney
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-25       Impact factor: 5.270

2.  Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study.

Authors:  Rebekka Lencer; Andreas Sprenger; James L Reilly; Jennifer E McDowell; Leah H Rubin; Judith A Badner; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; Brett A Clementz; John A Sweeney
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

Review 3.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

4.  Psychophysical isolation of a motion-processing deficit in schizophrenics and their relatives and its association with impaired smooth pursuit.

Authors:  Y Chen; K Nakayama; D L Levy; S Matthysse; P S Holzman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes.

Authors:  Yue Chen; L Cinnamon Bidwell; Daniel Norton
Journal:  Curr Psychiatry Rev       Date:  2006-11

Review 6.  Developing therapeutics for schizophrenia and other psychotic disorders.

Authors:  Gerard Marek; Kalpana Merchant
Journal:  NeuroRx       Date:  2005-10

7.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

8.  Behavioral signs of schizoidia and schizotypy in the biological parents of social anhedonics.

Authors:  Lindsay C Emmerson; Sarah L Miller; Jack J Blanchard
Journal:  Behav Modif       Date:  2009-05-12

9.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

10.  Incorporation of molecular data and redefinition of phenotype: new approaches to genetic epidemiology of bipolar manic depressive illness and schizophrenia.

Authors:  E S Gershon; J A Badner
Journal:  Dialogues Clin Neurosci       Date:  2001-03       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.